21 – 30 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
(
- Contribution to journal › Article
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
(
- Contribution to journal › Article
-
Mark
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function : a pre-specified quality of life sub-study from the REDUCE-AMI trial
(
- Contribution to journal › Article
-
Mark
IL1RAP Blockade with a Monoclonal Antibody Reduces Cardiac Inflammation and Preserves Heart Function in Viral and Autoimmune Myocarditis
(
- Contribution to journal › Article
- 2023
-
Mark
S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction
(
- Contribution to journal › Article
-
Mark
Vascular smooth muscle–specific YAP/TAZ deletion triggers aneurysm development in mouse aorta
(
- Contribution to journal › Article
-
Mark
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
(
- Contribution to journal › Article
-
Mark
Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population
(
- Contribution to journal › Article
-
Mark
Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow Reserve
(
- Contribution to journal › Article
-
Mark
Prevalence of angina pectoris and association with coronary atherosclerosis in a general population
(
- Contribution to journal › Article